Skip to main content

Investors

Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.

About Us

We are technology leaders in distribuited and connected diagnostics


Investors

The Ulysses Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.


18 November, 2022

Updates and announcements

Hyris and Singlabs signed a distributorship agreement for Singapore


Hyris and Signlabs will partner together to commercialize Hyris signature technology, Hyris System™, and Hyris testing solutions in Singapore.


Related links:

Singlabs